Xiu-Jin Ye (Xiujin Ye, Ye Xiujin)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 10

Top Topics

Allogeneic Hematopoietic Stem Cell Transplantation

Tyrosine Kinase

Prognostic Factors

Acute Lymphoblastic Leukemia

Top Venues

American journal of hematology

Clinics (Sao Paulo, Brazil)

Journal of experimental & clinical cancer research : CR

Annals of hematology

This page only lists publications with an associated author ORCID identifier.

Publications

Rong Wang, Yi Zhang, Jie Chang, Huafeng Wang, Yinjun Lou, Min Yang, Gaixiang Xu, Hongyan Tong, Wanzhuo Xie, De Zhou, Juying Wei, Wenyuan Mai, Xiu-Jin Ye, Haitao Meng, Jie Jin, Hong Hu Zhu
Venetoclax plus daunorubicin and cytarabine in newly diagnosed acute myeloid leukemia patients: A propensity score-matched analysis. Hematological oncology 42 (2) (2024)
De Zhou, Xianbo Huang, Mixue Xie, Lixia Zhu, Xin Huang, Xue-Ying Li, Xiudi Yang, Li Li, Jingjing Zhu, Xiaolong Zheng, Jianai Sun, Shuqi Zhao, Wenjuan Yu, Wanzhuo Xie, Hong-Yan Tong, Jie Jin, Hong Hu Zhu, Xiu-Jin Ye
Ruxolitinib combined with dexamethasone in adult patients with newly diagnosed Hemophagocytic lymphohistiocytosis: A single-center pilot trial. American journal of hematology (2023)
De Zhou, Xianbo Huang, Mixue Xie, Lixia Zhu, Xin Huang, Xue-Ying Li, Xiudi Yang, Li Li, Jingjing Zhu, Xiaolong Zheng, Jianai Sun, Shuqi Zhao, Wenjuan Yu, Wanzhuo Xie, Hong-Yan Tong, Jie Jin, Hong Hu Zhu, Xiu-Jin Ye
Ruxolitinib combined with dexamethasone in adult patients with newly diagnosed Hemophagocytic lymphohistiocytosis: A single-center pilot trial. American journal of hematology (2023)
Li Li, Rongrong Chen, De Zhou, Jianai Sun, Lulu Wang, Lixia Zhu, Huafei Shen, Wanzhuo Xie, Xiu-Jin Ye
The efficacy and cardiac toxicity of different-dose pegylated liposomal doxorubicin in elderly patients with diffuse large B lymphoma. Cancer medicine (2022)
Rongrong Chen, De Zhou, Lulu Wang, Lixia Zhu, Xiu-Jin Ye
MYD88 L265P and CD79B double mutations type (MCD type) of diffuse large B-cell lymphoma: mechanism, clinical characteristics, and targeted therapy. Therapeutic advances in hematology 13 (2022)
Mixue Xie, Lulu Wang, Qi Jiang, Xuxia Luo, Xin Zhao, Xueying Li, Jie Jin, Xiu-Jin Ye, Kui Zhao
Significance of initial, interim and end-of-therapy 18F-FDG PET/CT for predicting transformation risk in follicular lymphoma. Cancer cell international 21 (1) (2021)
Ting Shi, Huan-Ping Wang, Mixue Xie, Xue-Ying Li, Lixia Zhu, Xiu-Jin Ye
Prognostic significance of a normal karyotype in adult patients with BCR-ABL1-positive acute lymphoblastic leukemia in the tyrosine kinase inhibitor era. Clinics (Sao Paulo, Brazil) 75 (2020)
Xue-Ying Li, Jie-Jing Qian, Min Yang, Yi Zhang, Sha-Sha Wang, Hai-Tao Meng, Wen-Juan Yu, Hong-Yan Tong, Xiu-Jin Ye, Jie Jin, Hong-Hu Zhu
An oral, chemotherapy-free regimen (dasatinib plus prednisone) as induction and consolidation for adult patients with Philadelphia chromosome-positive acute lymphoblastic leukaemia. British journal of haematology 189 (6) (2020)
Shi Ting, Xie Mixue, Zhu Lixia, Li Xueying, Xie Wanzhuo, Xiu-Jin Ye
T315I mutation exerts a dismal prognosis on adult BCR-ABL1-positive acute lymphoblastic leukemia, and salvage therapy with ponatinib or CAR-T cell and bridging to allogeneic hematopoietic stem cell transplantation can improve clinical outcomes. Annals of hematology 99 (4) (2020)
Xianbo Huang, Feng Xiao, Yuan Li, Wenbin Qian, Wei Ding, Xiu-Jin Ye
Bypassing drug resistance by triggering necroptosis: recent advances in mechanisms and its therapeutic exploitation in leukemia. Journal of experimental & clinical cancer research : CR 37 (1) (2018)